Business Confidence Report on Pharmaceutical Industry, H1 2016 Research Analysis has “Pharmaceutical Industry Business Confidence Report H1 2016” complete research study spread in 49 pages in its database. The report highlights various areas in which industry executives intend to invest over the next six months.

The existing economic environment is stable for the pharmaceutical industry, and customer confidence levels will remain constant in H1 2016 (January 2016–June 2016). Companies are slightly optimistic about economic conditions in North America and Asia-Pacific due to positive momentum in the US manufacturing and production sectors, firm domestic demand, strong government expenditure in India, and robust private consumption and export growth in South Korea and Vietnam. Over the next six months the industry will increase its expenditure towards new product development and IT infrastructure. Moreover, companies operating in Asia-Pacific forecast their budget allocation for pharmaceutical equipment to increase significantly in 2016, compared to 2015. The pharmaceutical Industry Business Confidence Survey H1 2016 examines executives’ opinion on the business environment over January–June 2016. It also highlights existing economic conditions, supplier price variations, sales performance, industry and company growth outlook, spending patterns, and key priorities. Additionally, the report includes trends in the pharmaceutical equipment market, analysis of the procurement budget allocations, and leading suppliers of pharmaceutical equipment. View full report with complete Table of Contents @

Key Finding

-In total, 43% of pharmaceutical industry business executives expect the global economy to be stable in H1 2016 (January 2016–June 2016). Furthermore, 33% of survey respondents anticipate a favorable or very favorable economic environment

-Overall, 83% of respondents who operate in Europe are optimistic over company growth prospects, while no executives anticipate a negative impact on the industry in the region
-Business executives operating in the Rest of the World region anticipate the highest increase in staff headcount growth over the next six months
-In H1 2016, the majority of business executives from North America are concerned about the performance of North American economies, the performance of the Eurozone, and cybercrime
-Survey results reveal that 41% of pharmaceutical industry respondents who operate in Asia-Pacific expect an increase of 1–5% in the budget for pharmaceutical equipment during 2016

The report offeres Current state of the global economy, company and industry growth outlook, change in customer confidence, supplier prices projection, change in staff headcount and sales performance, significant investment activities, business concerns, key priorities, purchase preferences and budget allocation . Place a DIRECT purchase order of complete research study @

Few points from Table of Contents:

Economic State, growth prospects and customer confidence  
Existing economic environment 
Industry and company growth outlook
Expected change in customer confidence  

Supplier prices, staff headcount and sales performance 
Supplier prices expectations 
Anticipated change in staff head count and sales projections 
Anticipated change in spend on key activities 

Business concerns and organizational priorities  
Level of concerns and expected impact  
Significance of potential business priorities 

For any Inquiry on this research @ . 

Media Contact
Company Name: ReportsWeb
Contact Person: Rajat Sahni
Phone: +1-646-491-9876
Country: United States